Chapter 63 Transplant improves hemiparkinsonian syndrome in nonhuman primate: intracerebral injection, rotometry, tyrosine hydroxylase immunohistochemistry
- 1 January 1988
- book chapter
- Published by Elsevier
- Vol. 78, 491-496
- https://doi.org/10.1016/s0079-6123(08)60322-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinePublished by Elsevier ,2003
- Primate neostriatal neurons containing tyrosine hydroxylase: Immunohistochemical evidenceNeuroscience Letters, 1987
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- FETAL NEURONAL GRAFTS IN MONKEYS GIVEN METHYLPHENYLTETRAHYDROPYRIDINEThe Lancet, 1986
- The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmosetNeuroscience Letters, 1985
- Techniques for improving stereotaxic accuracy in Macaca fascicularisJournal of Neuroscience Methods, 1985
- Adrènal medulla grafts survice and exhibit catecholamine-specific fluorescence in the primate brainExperimental Neurology, 1984
- A chronic, stereotaxic guide-tube platform for intracranial injections in macaquesJournal of Neuroscience Methods, 1981
- Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testingBrain Research, 1980
- Cellular localization of tyrosine hydroxylase by immunohistochemistry.Journal of Histochemistry & Cytochemistry, 1975